Diclogel

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Diclogel

What is Diclogel? Foundational Overview

This section defines the identity, composition, and general purpose of the product Diclogel, adhering strictly to non-clinical and non-prescriptive content guidelines.

Property Description
Active ingredient Diclofenac (as the diethylamine salt)
Form Gel (topical formulation)
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
Common use Providing localized relief from pain and inflammation
Origin Synthetic compound

What is Diclogel and Its Pharmacological Identity?

Diclogel is a topical formulation whose active ingredient is Diclofenac, a substance formally classified as a Nonsteroidal Anti-inflammatory Drug (NSAID). This synthetic compound is chemically categorized as a derivative of phenylacetic acid.

As an NSAID, the core function of Diclofenac is established through its action as a Cyclooxygenase (COX) inhibitor. This mechanism is characterized by its anti-inflammatory effect and analgesic property, supporting its use in scenarios involving musculoskeletal discomfort. The product is considered a monosegment preparation, relying exclusively on this one therapeutic substance.


Composition, Form, and Application Type

The product is supplied as a gel, a specific topical formulation intended for cutaneous application (application to the skin). The essential active component used in this specific form is typically Diclofenac diethylamine, which is a salt variant that aids the drug's ability to penetrate the skin barrier.

The gel preparation utilizes an aqueous-alcoholic gel base (hydroalcoholic vehicle). This specific base is used for facilitating percutaneous absorption—the process by which the Diclofenac is delivered through the skin to the targeted underlying tissues, such as muscles and joints. This application type is designed to ensure the medicine concentrates its effect primarily at the site of discomfort. This formulation strategy allows the user to target inflammation directly where the discomfort is felt.


General Purpose: How This NSAID Gel Provides Relief

The general purpose of this specific NSAID gel is to provide targeted, localized pain relief and reduce discomfort stemming from inflammation, such as the kind associated with a minor strain or sprain. By concentrating the drug's core anti-inflammatory effect and analgesic property at the site of application, the product offers a localized benefit.

This targeted method provides antirheumatic activity and helps to alleviate acute discomfort and tenderness associated with localized issues. The goal is to address the local inflammatory process, which is often a source of pain, and contribute to improved comfort and range of motion in the affected area.

Regulatory References

  1. NIH StatPearls: Diclofenac

What side effects are possible with Diclogel?

Possible Side Effects and Safety Information

The safety profile for Diclofenac topical gel is structured by governmental regulatory authorities based on the frequency and type of documented adverse reactions, which are primarily localized due to the mode of application. The information presented is derived from official regulatory labeling.


Documented Adverse Reactions

The most frequent adverse reactions affect the Skin and Subcutaneous Tissue Disorders at the application site. Frequency classifications are based on standard regulatory standards:

Frequency Category Representative Adverse Reactions
Common Dermatitis, rash, pruritus (itching), erythema (redness)
Rare Bullous dermatitis (severe blistering)
Very Rare Photosensitivity reaction, systemic hypersensitivity reactions (e.g., asthma, angioedema)

Serious Safety Considerations

The regulatory label documents the potential for Very Rare but serious systemic adverse reactions, consistent with the overall Nonsteroidal Anti-inflammatory Drug (NSAID) class. These risks include severe skin reactions (e.g., Stevens-Johnson Syndrome) and, with large or prolonged use, the possibility of gastrointestinal bleeding or cardiovascular thrombotic events.

Population-Specific Constraints

The use of Diclofenac topical gel is contraindicated during the third trimester of pregnancy due to the risk of fetal toxicity and is not authorized for use in children and adolescents under 14 years of age. Caution is required for individuals with a history of asthma or allergic reactions to aspirin or other NSAIDs, as well as in patients with existing renal or hepatic impairment.

Overdose and Emergency Response

Overdose and When to Seek Help — Official Regulatory Information

The regulatory profile for Diclogel (Topical Diclofenac) states that an overdose from proper application is generally unlikely due to the low systemic absorption of the gel. The manifestations and severe risks described in official labeling are primarily relevant to cases of inadvertent oral ingestion or excessive use leading to high systemic exposure.

Classification Documented Overdose Manifestations
Expected Signs Gastrointestinal complaints, nausea, vomiting, epigastric pain, headache, and dizziness are potential signs of high systemic exposure.
Severe Outcomes Risk of serious systemic NSAID effects including gastrointestinal bleeding (ulceration/perforation), cardiovascular thrombotic events (myocardial infarction or stroke), and renal or hepatic toxicity.

Required Emergency Actions and Management

Official regulatory guidance mandates that users seek immediate medical help or contact a Poison Control Center right away if the gel is inadvertently swallowed. Urgent medical attention is required for the onset of serious symptoms, such as chest pain, shortness of breath, weakness on one side of the body, or vomiting blood.

Management is symptomatic and supportive. Regulatory documents state that no specific antidote is known for Diclofenac poisoning. In instances of recent, significant ingestion, general therapeutic measures, including the consideration of gastric lavage or activated charcoal, are procedures described in the official guidance.

Therapeutic Uses of Diclogel

What Diclogel Treats: Main Uses and Benefits


The primary role of this topical medication is to provide localized symptomatic relief across key musculoskeletal domains involving symptoms related to physical discomfort and inflammatory states. It is commonly used to address symptoms that create noticeable physiological strain and interfere with daily functioning.

Key Therapeutic Domains

Diclogel is commonly used to help with a range of conditions presenting with acute or recurrent episodes of localized discomfort. Its therapeutic relevance is seen in the management of acute pain from soft-tissue injuries such as muscle strains and joint sprains, as well as in providing support for the localized symptoms of chronic issues like osteoarthritis, tendonitis, and bursitis. The medication helps address symptom clusters that appear suddenly and fluctuate, offering symptomatic relief that helps patients cope more steadily.

Targeted Relief and Patient Benefit

This topical treatment is generally applied in scenarios where additional symptomatic support is needed for pain, tenderness, and stiffness, particularly in joints and soft tissues. It is commonly used to help with symptoms of localized arthritis in accessible areas like the hands and knees, and assists with managing the initial, difficult episodes following minor injuries. Ultimately, the product contributes to improved day-to-day comfort and supports patients during episodes of heightened discomfort by helping ease the overall symptom burden.

Quick Fact: Relief for Localized Inflammation This medication is considered relevant for easing symptoms that are specifically related to inflammatory or irritative states in the muscles and joints.

Regulatory References

  1. NIH DailyMed Overview

Eligibility and Restrictions for Use

The eligibility for using Diclogel is strictly defined by official regulatory criteria, primarily related to age, physiological status, and underlying health conditions.

Contraindicated Populations

Category Non-Eligibility Status
Hypersensitivity Patients with a known allergy to diclofenac or any component of the gel.
NSAID Reactions Patients who have experienced asthma, hives, or other allergic-type reactions after taking aspirin or other NSAIDs.
Surgical Setting Use is prohibited in the setting of coronary artery bypass graft (CABG) surgery.
Pregnancy Stage Use is contraindicated starting at 30 weeks gestation (third trimester).

Age and Condition-Specific Limitations

  • Pediatric Use: Safety and efficacy have not been established in children under 14 years of age, and use is contraindicated in this group per some regulators.
  • Geriatric Use: Older adults require careful monitoring due to an increased risk of potential adverse effects related to kidney, heart, or gastrointestinal function.
  • Severe Comorbidities: Use must be avoided in patients with advanced renal disease or severe heart failure unless the clinical benefits outweigh the risks of worsening the condition.
  • Skin Integrity: The gel must not be applied to non-intact or damaged skin, open wounds, or infections.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interaction Scope

Medicinal product categories with documented interactions are primarily linked to the systemic risks of the Nonsteroidal Anti-inflammatory Drug (NSAID) class. These include oral NSAIDs, Anticoagulants (such as Warfarin), Diuretics, and certain Antihypertensives (ACE Inhibitors, ARBs). Specific interaction concerns are documented for Digoxin and, theoretically, for Lithium and Methotrexate. The mechanistic basis documented in regulatory sources includes pharmacodynamic interactions (additive risk of bleeding) and pharmacokinetic effects (potential to alter drug concentrations).


Interaction Classifications

Interaction severity classifications are defined in official government documents. The product is contraindicated in the setting of Coronary Artery Bypass Graft (CABG) surgery and with drugs like Ketorolac. The co-administration of oral NSAIDs and Aspirin is not generally recommended due to the officially listed increased risk of serious gastrointestinal adverse events.


Official Interaction Statements

  • Co-administration with Anticoagulants or Antiplatelet Agents is associated with an officially documented increased risk of serious bleeding.
  • The drug may diminish the antihypertensive or natriuretic effect of Diuretics and some blood pressure medicines.
  • Concomitant use with Digoxin can increase serum concentration and prolong the half-life of Digoxin.
  • The treated skin area must not be used concomitantly with other topical products and exposure to natural or artificial sunlight must be avoided.

Connection to the Overall Interaction Profile

The regulatory documents define the product’s interaction structure around managing the pharmacodynamic risk inherent to the NSAID class, particularly the potential for additive bleeding when co-administered with systemic agents. Official labels also detail specific pharmacokinetic effects and include administration-site constraints that prohibit use with other topicals or exposure to sunlight.

Mechanism of Action

The mechanism of Diclofenac involves localized pharmacodynamic action and the modulation of chemical signaling in peripheral tissues.

Molecular Inhibition of Prostanoid Synthesis

The core action of Diclofenac is the competitive inhibition of the Cyclooxygenase ( COX) enzymes, targeting COX-2 preferentially at the application site. This specific inhibition blocks the conversion of arachidonic acid into prostaglandin E2 ( PGE2), which functions as a key mediator in the inflammatory cascade.

Modulation of Local Inflammatory and Nociceptive Pathways

The reduction of PGE2 concentration locally results in a physiological decrease of vasodilation and extravasation (fluid leakage into tissue). Furthermore, lower levels of PGE2 reduce the chemical sensitization of peripheral nociceptors (pain-sensing nerves), which is the mechanistic basis for a physiological modulation of the inflammatory and pain signaling pathways.

Confining Mechanistic Action via Topical Delivery

The topical gel formulation is designed to create a high concentration gradient, ensuring the enzyme inhibition mechanism is delivered to the underlying muscles and joints. This focused delivery supports effective saturation of local COX enzymes, limiting the resulting mechanistic action primarily to the target tissue and its immediate physiological pathways.

Dosage and Administration Information

How Diclogel is Used: Official Administration Guidelines

The administration of Diclofenac gel is governed by strict, standardized principles of localized application and precise measurement. The product is intended exclusively for topical or cutaneous use, where the gel is applied directly to the skin over the affected area.

Standard Adult Dosing and Frequency

The official dosage regimen requires the gel to be applied four times daily (QID). The specific amount of gel per application is weight-based and determined by the site of application.

Joint Location Dose per Application Maximum Single Joint Dose per Day
Upper Extremities (Hand, Wrist, Elbow) 2 grams (g) 8 grams
Lower Extremities (Knee, Ankle, Foot) 4 grams (g) 16 grams

The maximum total daily dose across all affected joints must not exceed 32 grams. Treatment duration is typically limited to the shortest period necessary to meet treatment goals.

Administration Procedure and Constraints

Accurate application requires the prescribed amount of gel to be measured using a dosing card supplied with the product, after which it is gently rubbed into the entire affected area. The gel must only be applied to intact, non-diseased skin.

After application, the treated area should not be washed or bathed for at least one hour, and patients must wait at least 10 minutes before covering the skin with clothing or gloves. For older adults, the usual adult dose may be applied, though close monitoring is generally part of the overall clinical strategy.

Recent Clinical Evidence

Research Evidence / Overview of Studies

This section summarizes the findings from clinical research and studies related to the investigational drug. This information is descriptive of the research design and reported results, not prescriptive of medical treatment.

Mechanism of Action and Early Studies

Studies evaluated whether the drug's mechanism of action involves specific biological actions. This exploratory work was primarily conducted in Phase 1 and Phase 2 trials to understand dose-response and potential side effect profiles. Research investigated the intended action of the formulation.

Efficacy Trials (Phase 3)

Phase 3 trials represent the largest body of evidence. These trials focused on patients with chronic knee osteoarthritis who met specific clinical criteria.

  • Measured Effects: One large-scale Phase 3 trial reported that patients reported changes in measurements of swelling and tenderness over a 12-week period. Research examined the use of the drug in elderly patients. Studies examined the timing of reported effects.
  • Comparison to Placebo: A meta-analysis suggests this treatment indicated a difference compared to placebo. The research indicates findings related to this new therapy.
  • Long-Term Research: Other research examined whether combining the drug with standard physical therapy is associated with changes in measured physical abilities. The studies reported findings in the majority of users.

Safety and Patient Groups

Clinical safety data was collected across all trial phases. Researchers specifically looked at common adverse events and serious adverse events.

  • Cardiovascular Health: Studies involving patients with pre-existing heart conditions examined the effects of various doses.
  • Drug Interactions: Investigations were conducted to see if the drug changed the activity of commonly co-administered medications, such as non-steroidal anti-inflammatory drugs (NSAIDs) and blood thinners. Findings were mixed regarding effects on bleeding time when used concurrently with specific anticoagulants. Information about stopping any medication is typically discussed with a doctor.

Key Studies & References

  1. Diclofenac - StatPearls - NCBI Bookshelf (General Drug and Mechanism Information)
  2. Diclofenac Topical (arthritis pain): MedlinePlus Drug Information (Dosing/Interaction Context)

Frequently Asked Questions (FAQ)

Common questions about Diclogel (FAQ)


Q: Does Diclogel contain steroids?

A: No. Official regulatory documents classify the active ingredient, Diclofenac, as a Nonsteroidal Anti-inflammatory Drug, or NSAID. This indicates that it works through a different mechanism than corticosteroid medicines.

Q: How quickly does Diclogel start working for muscle pain?

A: Diclogel is not intended for immediate pain relief upon application. Clinical data indicates that for conditions like arthritis pain, the full therapeutic effect may take up to 7 days to be fully observed.

Q: How long does the effect of Diclogel last after I put it on?

A: The duration of effect may vary based on physiological factors. Clinical studies suggest that a single application can provide sustained analgesia for up to 48 hours (as shown in UV-induced pain models), although systemic levels may be detectable for around 8 hours.

Q: Does Diclogel get absorbed into the bloodstream?

A: Yes, the active ingredient is absorbed systemically into the bloodstream, even though the gel is designed for localized delivery. Regulatory data indicates this systemic absorption is low, typically around 6% compared to taking an equivalent oral dose.

Q: What is the recommended period of time to use Diclogel before taking a break?

A: Official labeling for the over-the-counter (OTC) version specifies a time limit for continuous use. Consumers are advised to stop the product and consult a healthcare provider if pain lasts for more than 21 days or worsens during the application period.

Q: Can I use Diclogel if I am taking over-the-counter pain relievers like Advil or Tylenol?

A: Official guidance does not recommend using Diclogel concurrently with other oral NSAIDs, such as ibuprofen (Advil), as this may increase the risk of side effects. While no clinically significant interaction has been established with Acetaminophen (Tylenol), adherence to the maximum daily dose for any over-the-counter medication is specified.

Q: What is the concentration (strength) and how many different formulas of Diclogel are available?

A: Diclofenac topical gel is regulated and manufactured in at least two different strengths. A 1% gel is commonly approved for arthritis pain, while a stronger 3% gel is approved for different skin conditions, such as actinic keratosis.

Q: Is Diclogel considered a prescription-only or over-the-counter medicine internationally?

A: The regulatory status of Diclogel depends on the specific strength and the region. The 1% topical gel, which is used for arthritis pain, has been made available as an over-the-counter (OTC) product in many countries, though stronger formulations may remain prescription-only.

Q: Does Diclogel have an expiration date I should watch out for?

A: Yes. All medicinal products have an official expiration date to ensure quality and potency. Regulatory instructions specify that disposal of unused or expired medicine is required in accordance with local guidelines and should not be done via wastewater or household waste.

Q: Can I use Diclogel with a heating pad or ice pack?

A: Official medication guides indicate that heating pads are not to be used over the area where the gel has been applied. The use of occlusive (air-tight) dressings is also restricted unless a healthcare provider specifically directs otherwise.

Q: Is it necessary to wash my hands after using Diclogel?

A: Yes. According to official administration procedures, the applicator's hands are to be washed thoroughly immediately after applying the gel. This step is only omitted if the hands themselves are the area being treated.

Q: What does the acronym NSAID mean in relation to Diclogel?

A: NSAID stands for Nonsteroidal Anti-inflammatory Drug. This classification describes the chemical category and function of Diclofenac, which works to reduce pain and inflammation without relying on steroid compounds.

Q: What happens if I use Diclogel more often than recommended?

A: Exceeding the maximum total daily dose, which is generally 32 grams across all joints, results in increased systemic absorption of Diclofenac. Regulatory labels indicate that this higher exposure elevates the risk of serious systemic NSAID-related side effects, such as cardiovascular thrombotic events and gastrointestinal bleeding.

Q: Is Diclogel the same as regular Diclofenac pills?

A: No, they are fundamentally different in how they are absorbed. The topical gel is designed to target pain locally with minimal systemic absorption, whereas oral pills are ingested for general body action, leading to significantly higher systemic absorption throughout the body.

Q: Why is Diclogel sometimes used instead of pills for localized pain?

A: Diclogel's mechanism involves concentrating the active ingredient at the site of discomfort through topical application. This process achieves the anti-inflammatory effect while providing significantly lower systemic absorption, a factor which may help reduce the risk of common oral NSAID side effects like stomach issues.

Q: Is Diclogel used for back pain or just joint pain?

A: The official FDA approval for the gel is specifically for arthritis pain in certain joints of the extremities, such as the hands, knees, and feet. The product's safety and effectiveness for use on the spine, hip, or back pain have not been evaluated in the official clinical trials that support its approval.

Q: Can I use Diclogel on a bruised area?

A: Official regulatory guidance requires the gel only be applied to clean, dry, and intact skin. Use is contraindicated on areas with cuts, open wounds, infections, rashes, or severely peeling skin, which is why bruising should be considered against the requirement that the gel only be applied to intact skin.

Q: Is it okay to use Diclogel if I have sensitive skin?

A: The official safety profile indicates that local skin reactions are the most commonly reported adverse effects associated with the gel. These documented reactions include dermatitis, rash, redness (erythema), and itching.

Q: Can Diclogel be used for general body aches?

A: The gel is approved for the localized pain of osteoarthritis in specific joints. Its mechanism is designed to concentrate its effect locally, meaning its use for general body aches (systemic discomfort) is outside of the product's defined therapeutic scope.

Q: Why is the active ingredient in Diclogel called a non-steroidal anti-inflammatory drug?

A: The name indicates that the drug works to reduce pain and inflammation through a different mechanism than a steroid drug. This classification is given because its chemical structure and pharmacological action do not involve the adrenal hormone system.

Q: Can I use Diclogel on my neck or shoulder?

A: Official FDA labeling for the 1% gel specifies use only on the hands, wrists, elbows, feet, ankles, and knees. Use on the neck or shoulder has not been studied or approved.

How should Diclogel be stored and disposed of?

How to Store and Dispose of Diclogel?

Diclogel (diclofenac topical gel) must be stored strictly according to official regulatory requirements to maintain its stability and effectiveness.


Storage Requirements

  • Temperature: Store at controlled room temperature, specifically between 20°C to 25°C (68°F to 77°F). Brief excursions are permitted.
  • Protection: It is mandatory to Keep from freezing and to Keep the container tightly closed.
  • Safety: The product must be stored out of the sight and reach of children.

Disposal

Official instructions require that unused or expired medicine must be disposed of in accordance with local requirements. The gel must not be thrown away via wastewater or household waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Diclogel found in:

A-Z Index: